Sepsis Diagnostics market forecast to see 9.2% CAGR to 2028

The proposed Sepsis Diagnostics market report will encompass all the qualitative & quantitative aspects including the market size, market estimates, growth rates & forecasts & hence will give you a holistic view of the market. The study also includes detailed analysis of market drivers, restraints, technological advancements & competitive landscape along with various micro & macro factors influencing the market dynamics.

The sepsis diagnostics market is projected to reach US$ 1,226.52 million by 2028 from US$ 661.83 million in 2021; it is expected to grow at a CAGR of 9.2% from 2021 to 2028.

Factors such as the surging incidence of sepsis due to increasing nosocomial infections and rising demand for rapid diagnostic tests leading to increasing product launches drive the sepsis diagnostics market growth.

Sepsis is a serious and life-threatening clinical condition that generally results from primary bacterial infection or, less frequently, from a fungal and/or viral infection. Three stages of sepsis are sepsis, severe sepsis, and the final stage of septic shock. Sepsis diagnostics is the study of diagnosis of this condition.

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis

https://www.theinsightpartners.com/sample/TIPHE100001391/?utm_source=OpenPR&utm_medium=10366

Furthermore, the Sepsis Diagnostics market full research study is designed on account of the fact that each segment is individually assessed and then collated to form the whole market, the study can be tailor-made to fit your exact requirements.

The structure of the Sepsis Diagnostics market report can be categorized into following sections:          

Section 1: scope of the report & research methodology

Section 2: key takeaways                                                                   

Section 3: market variables & their impact on growth and analytical tools providing high level insights into the market dynamics and growth pattern

Section 4: market estimates and forecasts (with the base year as 2019, historic information of 2016 & 2018 and forecast from 2021 to 2028). Regional and country level estimates and forecasts for each category which are summed up to form the global market.

Section 5: competitive landscape. Attributes such as strategy framework, competitor categorization are included to provide elaborate details on the market structure & strategic undertakings as well as their impact.

Product Insights

Based on product, the global sepsis diagnostics market is segmented into instruments, reagents and assays, blood culture media, and software. In 2021, the blood culture media segment held the largest share of the market. According to the Journal of the Academy of Clinical Microbiologists report, blood culture media remains one of the most critical investigations in the sepsis management as it allows identification of the responsible organism for sepsis, appropriate choice of empirical and specific antibiotics, and points towards further investigations for identifying the focus on infection. A blood culture media is recommended for all septic patients. However, the software segment is anticipated to register the highest CAGR in the market during the forecast period.

Technology Insights

Based on technology, the global sepsis diagnostics market is segmented into molecular diagnostics, flow cytometry, microfluidics, immunoassay, biomarkers, and microbiology. In 2021, the microbiology segment held the largest share of the market. Rapid and specific pathogen identification is important for sepsis treatment, and microbiological techniques act as the gold standard for sepsis pathogen identification that can be done through blood culture followed by sub culturing and pathogen identification through biochemical or microscopic means. However, the molecular diagnostics segment is expected to register the highest CAGR in the market during forecast period.

Method Insights

Based on method, the global sepsis diagnostics market is bifurcated into automated diagnostics and conventional diagnostics. In 2021, the conventional diagnostics segment held a larger share of the market. However, the automated diagnostics segment is expected to register a higher CAGR in the market during forecast period. Conventional diagnostics procedure for sepsis takes a few days. Thus, conventional diagnostics method is slowly adopted than automated diagnostics. Also, companies focus on developing automated diagnostics based on advanced technologies, such as molecular diagnostics for detecting sepsis.

Test Type Insights

Based on test type, the global sepsis diagnostics market is segmented into point-of-care tests and laboratory tests. In 2021, the laboratory tests segment held a larger share of the market. However, the point-of-care tests segment is expected to register a higher CAGR in the market during forecast period. POC platforms can lead to timely intervention with appropriate therapeutics as it simplifies the needs of the diagnostics process by offering accessible and affordable clinical information to detect sepsis at a much earlier stage.

Pathogen Insights

Based on pathogen, the global sepsis diagnostics market is segmented into bacteria sepsis, fungal sepsis, and others. In 2021, the bacteria sepsis segment held the largest market share. Moreover, the same segment is expected to register the highest CAGR in the market during forecast period.

The prominent/emerging players in the Sepsis Diagnostics market research include:

Abbott
HOFFMANN-LA ROCHE LTD.
Immunexpress Inc.
BD
Danaher
Luminex Corporation
Thermo Fisher Scientific Inc.
bioMerieux SA.
T2 Biosystems, Inc.
Axis-Shield Diagnostics Ltd

The Sepsis Diagnostics market company profiles are individually represented for all major participants and indices such as financial performance, strategic initiatives, product portfolio & company overview.

Have a 15-minute-long discussion with the lead analyst and author of the report in a time slot decided by you. You will be briefed about the contents of the report and queries regarding the scope of the document will be addressed as well

https://www.theinsightpartners.com/speak-to-analyst/TIPHE100001391/?utm_source=OpenPR&utm_medium=10366

Company overview:                                                              

Company overview provides the information about location of the company where it is headquartered along with the established year, employee strength as of 2017, regions where the company is operating and the key business areas.

Financial performance:          

Overall company/segment revenue for the year 2019, 2018, and 2017 is provided in the sub title "financial performance" (public listed companies) along with the analysis and explanation of the increase or decrease in the same due to factors such as mergers & acquisition, profit or loss in any strategic business unit (sbus) and others.

Product benchmarking:                                                                          

Product benchmarking comprises the comprehensive list of products pertaining to the respective market along with the application and key features.

Strategic initiatives:         

Insights pertaining to the new product launch, strategic collaboration, mergers and acquisition, regulatory approval, and other developments by the company in market are covered under strategic initiatives section.

Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods

https://www.theinsightpartners.com/buy/TIPHE100001391/?utm_source=OpenPR&utm_medium=10366

The Sepsis Diagnostics market research study is designed keeping in focus all the major countries. Although, all these countries & their market trends were accounted for while composing it, detailed sections are available for only the spearheads. In case if you would be interested in specific countries which are not covered in the current scope, kindly share the list & we can customize the study based on the geographical scope defined by you.

Contact us:                                                                                                         

If you have any queries about this report or would like further information, please contact us:

North america:          +1 646 491 9876                                            

Asia-pacific:               +91 20 6727 8686                                           

Email:                         sales@theinsightpartners.com                 

About us:                                                                                   

The insight partners is a one stop industry research provider of actionable solutions. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are specialist in industries such as semiconductor and electronics, aerospace and defense, automotive and transportation, Sepsis Diagnostics, healthcare it, manufacturing and construction, medical device, technology, media and telecommunications, chemicals and materials.

Our research model is very simple. We believe in client servicing and delivering best quality to our customers. Through our research content, we are making sure that our customers get value of their money along with better quality data and analysis.

Our research content is majorly focused towards market trends in terms of market sizing, competitive landscaping, company analysis, regional or country analysis etc. We provide detailed break-up of segmentation in terms of geography, technology, product and services etc.; which helps our clients to get a deeper analysis on various research topics.

                                                                                                      

                                                                                                                

                                                                                                       

                                                                                                                   

This release was published on openPR.